Biofrontera Inc. to Report Third Quarter Financial Results on November 30, 2021
23 nov. 2021 08h15 HE | Biofrontera Inc.
WOBURN, Mass., Nov. 23, 2021 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, will report financial...
Corbus Pharmaceuticals Reports Third Quarter Financial Results and Provides Corporate Updates
10 nov. 2020 07h05 HE | Corbus Pharmaceuticals Holdings, Inc.
Company intends to shorten fully-enrolled Phase 3 dermatomyositis trial to 28 weeks from 52 weeks following recent developments in competitive landscape; data now expected as early as the second...
Advantego Announces Third Quarter Financial Results
20 nov. 2019 05h00 HE | Advantego Corporation
Denver, CO, Nov. 20, 2019 (GLOBE NEWSWIRE) -- Advantego Corporation (OTCQB: ADGO) today announced financial results for the third quarter ended September 30, 2019. For the third quarter, Advantego...